27 May 2021 / 21:32 H. Pix for representational purpose only. Reuters
PUTRAJAYA: The AstraZeneca vaccine will be included back into the National Covid-19 Immunisation Programme mainstream vaccine list following the public’s encouraging response towards the vaccine, said National Covid-19 Immunisation Programme Coordinating Minster Khairy Jamaluddin.
He said the decision to implement the voluntary or opt-in method was made after seeing the public’s hesitancy to accept the AstraZeneca vaccine due to reports linking the vaccine to cases of blood clots.
“After seeing the vaccine being well-received, we see that the hesitance towards the AstraZeneca vaccine has been reduced.
“So we made the decision that we will not implement AstraZeneca through an opt-in method for the upcoming months but instead include it back into the National Covid-19 Immunisation Programme’s mainstream vaccine list,” he said during an online media conference today.
KUALA LUMPUR, May 27 After yesterday’s hiccups left many Malaysians frustrated after failing to register for the latest round of AstraZeneca’s Covid-19 vaccine, some have today breathed a sigh of relief as they have been given appointments. On social media platforms such as Twitter, a.
IPOH: Pharmaniaga Bhd is confident that it can supply around 8.6 million doses of the Sinovac Covid-19 vaccine by the end of June.
Pharmaniaga group managing director Datuk Zulkarnain Md Eusope said some 3.6 million doses of vaccines would be available in May with another five million in June.
He said some of the vaccine supply would be bottled at its wholly-owned subsidiary Pharmaniaga LifeScience Sdn Bhd (PLS) plant, referred to as filled and finished vaccines, with the rest coming fully finished from China. We are ready to ramp up production from two million to four million doses a month in order to help the government expedite the vaccination programme and achieve herd immunity.
24 May 2021 / 21:25 H.
KUALA
LUMPUR: The Covid-19 Vaccine Supply Access Guarantee Special Committee (JKJAV) has been urged to review the AstraZeneca voluntary vaccine registration process, especially involving the elderly so as to increase the percentage of registrants from this target group.
Universiti Putra Malaysia Medical and Public Health Faculty medical expert Assoc Prof Dr Malina Osman said the matter should be considered in detail to speed up the vaccination process for the group and help reach the vaccination target of 80% of the population to achieve herd immunity.
She said an aggressive registration approach of engaging the elderly was better because the group might face difficulty registering online without assistance from others.
Aggressive push for elderly to register for AstraZeneca vaccine needed
May 24, 2021
KUALA LUMPUR – The COVID-19 Vaccine Supply Access Guarantee Special Committee (JKJAV) has been urged to review the AstraZeneca voluntary vaccine registration process, especially involving the elderly so as to increase the percentage of registrants from this target group.
Universiti Putra Malaysia Medical and Public Health Faculty medical expert Assoc Prof Dr Malina Osman said the matter should be considered in detail to speed up the vaccination process for the group and help reach the vaccination target of 80 per cent of the population to achieve herd immunity.
Advertisement
She said an aggressive registration approach of engaging the elderly was better because the group might face difficulty registering online without assistance from others.